Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Current clinical pharmacology

Volumn 8, Issue 4, 2013, Pages 358-369

  Chapleau, Christopher A ^a   Lane, Jane ^b   Pozzo Miller, Lucas ^b   Percy, Alan K ^b  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ANIMAL; DISEASE MODEL; DRUG DESIGN; FEMALE; GENETICS; HUMAN; MOUSE; MUTATION; PATHOPHYSIOLOGY; PHENOTYPE; RETT SYNDROME; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DESIGN; FEMALE; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICE; MUTATION; PHENOTYPE; RETT SYNDROME;

EID: 84906933431     PISSN: None     EISSN: 22123938     Source Type: Journal    
DOI: 10.2174/15748847113086660069     Document Type: Review

References (0)